Home
Obi Profile
Fees
Services
News
Publications
Contact
You are here:
Title Details
Search
Login
INCREASING DRUG BIOAVAILABILITY IN NALTREXONE THERAPY
No-Receipt date
2017-01727 - 19/05/2017
No-Filing date
20170401363 - 19/05/2017
No-Granting date
3092636 - 28/08/2017
No-EPO application date
11845186.3 - 02/12/2011
No-EPO granting date
2646031 - 22/02/2017
Gazette No-Publication date of application
-
Gazette No-Publication date of granted patent
8/2017 - 23/10/2017
Expiration date
03/12/2031
Kind of title
Validation of European Patent
Legal status
VALID
Priorities
US419395 P03/12/2010/US
Active Substance of Supplementary Certificates
-
IPC Classification
Ipc Class
A61P 3/04
A61K 31/485
A61K 31/137
Related Documents
Related Titles
Owners
Code
Firstname
Surname
Address
Town
ZIP
Country
761749
OREXIGEN THERAPEUTICS, INC.
3344 NORTH TORREY PINES COURT, SUITE 200
LA JOLLA, CA 92037
UNITED STATES OF AMERICA (USA)
Inventors
Code
Firstname
Surname
1873506
FLANAGAN, SHAWN
1873507
DUNAYEVICH, EDUARDO
Representatives
Code
Firstname
Surname
Address
Town
Zip
3190
KONSTANTINOS
KILIMIRIS "PATRINOS & KILIMIRIS DIKIGORIKI ETAIRIA"
CHATZIGIANNI MEXI 7
ATHINA (ATTIKIS)
11528
Contact
Code
Firstname
Surname
Address
Town
Zip
Country
8149
KONSTANTINOS
KILIMIRIS
CHATZIGIANNI MEXI 7
ATHINA (ATTIKIS)
11528
GREECE
Owners History
Title Instruments
Payments history
14 renewals have been done
© OBI all rights reserved
designed & developed by PROFILE S.A.
Certified QMS :
EN ISO 9001:2015
and
ΕΝ ISO 14001:2015
The project "Internet technological information diffusion from industrial property titles" is co-financed 70% by the European Regional Development Found and 30% by the Hellenic public sector (Operational programme "Competitiveness", Measure 4.4).